Mobile Application to Prevent Suicide (MAPS)
BehavioralSafety Planning Intervention, ecological momentary intervention smartphone app system, and bidirectional communication with study clinician.
NCT Number: NCT05202756
The primary aim of the present study is leverage existing infrastructure to develop novel technological features for a novel personalized smartphone intervention system, called the Mobile Application to Prevent Suicide (MAPS), and to establish feasibility, acceptability, safety, and estimate key parameters for primary outcomes (i.e., suicidal ideation and behavior; re-hospitalization), and target mechanisms.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Brown University, Providence, Rhode Island, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Safety Planning Intervention, ecological momentary intervention smartphone app system, and bidirectional communication with study clinician.
Safety Planning Intervention; ecological momentary assessment only
Time frame: 1 month
Measured using the Client Satisfaction Questionnaire, a self-report measure of satisfaction with treatment. Scores range from 8 to 32, with higher scores representing higher satisfaction.
Time frame: Baseline
Measured by recruitment rate.
Time frame: 6 months
Measured by dropout rate.
Time frame: 1 month
Feedback on qualitative interview.
Time frame: 1 month
Feedback on qualitative interview.
Time frame: 4 weeks
Measured by protocol completion rate.
Time frame: 4 weeks
Number of assessments completed out of total
Time frame: 6 months
Will be assessed using the Columbia Suicide Severity Rating Scale, items from the Modified Scale for Suicidal Ideation, and ecological momentary assessment of suicidal ideation and behavior. The Columbia Suicide Severity Rating Scale can provide presence/absence of suicidal ideation and suicidal behavior, as well as a suicidal ideation score ranging from 0 to 5 with higher scores representing more severe ideation, and a suicidal ideation intensity rating from 0-25 with higher scores representing more intense ideation.
Time frame: 6 months
Number of inpatient rehospitalizations will be assessed using the Treatment History Interview and medical records review.
Time frame: 6 months
Number of emergency department visits will be assessed using the Treatment History Interview and medical records review.
Time frame: 4 weeks
Coping strategy use will be measured in three ways: (1) when participants are prompted to use a coping strategy via MAPS, followup prompts ask whether or not they used the coping skill, (2) in each EMA survey, participants are asked whether or not they used any coping skills since the last survey, and (3) the system provides output with regard to how many times participants dial a support contact phone number through the MAPS app.
Time frame: 4 weeks
Negative affect will be measured using Positive and Negative Affect Scale (PANAS-X) items on ecological momentary assessment surveys. Each emotion item on the PANAS-X is rated on a 1-5 scale based on how participants feel, with 1 indicating "very slightly or not at all" and 5 indicating "extremely."
Time frame: 4 weeks
Coping self-efficacy will be measured using the Coping Self-Efficacy Scale. Self-efficacy for seeking mental health care will be measured by the Self-Efficacy to Seek Mental Health Care Scale. The total score can range from 0-260; the higher the score, the higher the level of coping self-efficacy.
Butler Hospital
Other
Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05180383
Behavior, Behavioral Symptoms
Providence, Rhode Island, United States
View Trial DetailsNCT03444935
Behavior, Behavioral Symptoms
Winnipeg, Manitoba, Canada
View Trial DetailsNCT05180331
Behavior, Behavioral Symptoms
Providence, Rhode Island, United States
View Trial DetailsNCT06225661
Behavior, Behavioral Symptoms
Calgary, Alberta, Canada
View Trial Details